Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study.
Leong, Kam-Hang, Yip, Hei-Tung, Kuo, Chien-Feng et al. · Journal of translational medicine · 2022 · DOI
Quick Summary
This study looked at over 12,000 people in Taiwan with ME/CFS and compared them to an equal number of similar people without the condition. Researchers found that people with ME/CFS are much more likely to also have depression, anxiety, sleep problems, and certain other illnesses like diabetes and rheumatoid arthritis. The study also found that doctors commonly prescribed antidepressants, anti-anxiety medications, pain relievers, and recommended exercise and therapy—treatments that earlier research suggested might help with ME/CFS symptoms.
Why It Matters
This large population-based study provides real-world evidence of which medical conditions commonly co-occur with ME/CFS and which treatments clinicians actually use, helping patients and doctors understand the full clinical picture of the disease. Identifying psychiatric and systemic comorbidities is crucial for comprehensive patient care and recognizing that ME/CFS often requires multi-faceted treatment approaches.
Observed Findings
ME/CFS patients showed significantly higher rates of depression, anxiety disorder, and insomnia compared to controls
Autoimmune and inflammatory conditions (rheumatoid arthritis, Sjögren syndrome, Crohn's disease, ulcerative colitis) were more common in the CFS cohort
Metabolic conditions including type 2 diabetes, dyslipidemia, and gout occurred more frequently in CFS patients
Antidepressants (SSRIs, SNRIs, TCAs), benzodiazepines, and analgesic medications were prescribed significantly more often to CFS patients
Psychotherapy and exercise therapy were recommended more frequently in the CFS group than controls
Inferred Conclusions
Psychiatric comorbidities, particularly depression and anxiety, are prevalent in ME/CFS and warrant heightened clinical awareness and screening
Clinicians treating ME/CFS employ pharmacological and behavioral strategies commonly used for symptom management in conditions with overlapping features
ME/CFS appears to co-occur with multiple systemic conditions, suggesting possible shared pathophysiological mechanisms or increased disease burden in this population
Remaining Questions
Did the prescribed treatments actually improve symptoms or outcomes in CFS patients, or were they simply prescribed without demonstrated benefit?
What This Study Does Not Prove
This study cannot prove that any of the observed treatments are effective—it only shows what doctors prescribed, not whether those treatments worked or improved outcomes. The association between CFS and comorbidities does not establish whether these conditions cause CFS, result from CFS, or share common underlying mechanisms. Additionally, findings from Taiwan's healthcare system may not directly apply to other countries or populations.
Tags
Symptom:Fatigue
Method Flag:PEM Not DefinedWeak Case DefinitionMixed Cohort
What are the causal relationships between CFS and its comorbidities—do these conditions cause CFS, does CFS predispose to these conditions, or do they share common biological mechanisms?
How do treatment patterns and comorbidity rates in Taiwan compare to other countries, and are these findings generalizable to other populations?
Why are certain conditions like Sjögren syndrome and herpes zoster more common in CFS, and what biological pathways might explain these associations?